Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 3
2000 2
2001 1
2002 2
2003 1
2004 4
2005 2
2006 2
2007 7
2008 1
2010 3
2011 8
2012 6
2013 3
2014 4
2015 3
2017 6
2020 4
2021 7
2022 12
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J, Nguyen AM, Li Q, Tzontcheva A, Iskold B, Green SA, Rosa C, Muccino DR, Smith JA; COUGH-1 and COUGH-2 Investigators. McGarvey LP, et al. Lancet. 2022 Mar 5;399(10328):909-923. doi: 10.1016/S0140-6736(21)02348-5. Lancet. 2022. PMID: 35248186 Clinical Trial.
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.
Smith JA, Kitt MM, Morice AH, Birring SS, McGarvey LP, Sher MR, Li YP, Wu WC, Xu ZJ, Muccino DR, Ford AP; Protocol 012 Investigators. Smith JA, et al. Among authors: mcgarvey lp. Lancet Respir Med. 2020 Aug;8(8):775-785. doi: 10.1016/S2213-2600(19)30471-0. Epub 2020 Feb 25. Lancet Respir Med. 2020. PMID: 32109425 Clinical Trial.
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma.
Khalfaoui L, Symon FA, Couillard S, Hargadon B, Chaudhuri R, Bicknell S, Mansur AH, Shrimanker R, Hinks TSC, Pavord ID, Fowler SJ, Brown V, McGarvey LP, Heaney LG, Austin CD, Howarth PH, Arron JR, Choy DF, Bradding P. Khalfaoui L, et al. Among authors: mcgarvey lp. Allergy. 2022 Oct;77(10):2974-2986. doi: 10.1111/all.15376. Epub 2022 May 25. Allergy. 2022. PMID: 35579040 Free PMC article. Clinical Trial.
Cough sensors from dental pulp.
McGarvey LP, Clarke R, Lundy FT. McGarvey LP, et al. Pulm Pharmacol Ther. 2017 Dec;47:16-20. doi: 10.1016/j.pupt.2017.08.001. Epub 2017 Aug 4. Pulm Pharmacol Ther. 2017. PMID: 28782711 Review.
Does idiopathic cough exist?
McGarvey LP. McGarvey LP. Lung. 2008;186 Suppl 1:S78-81. doi: 10.1007/s00408-007-9048-4. Epub 2007 Nov 16. Lung. 2008. PMID: 18008103 Review.
Acute and chronic cough.
McGarvey LP, Nishino T. McGarvey LP, et al. Pulm Pharmacol Ther. 2004;17(6):351-4. doi: 10.1016/j.pupt.2004.09.017. Pulm Pharmacol Ther. 2004. PMID: 15564075 Free PMC article. Review.
Common causes and current guidelines.
McGarvey LP, Polley L, MacMahon J. McGarvey LP, et al. Chron Respir Dis. 2007;4(4):215-23. doi: 10.1177/1479972307084447. Chron Respir Dis. 2007. PMID: 18029434 Free article. Review.
Clinical cough and its mechanisms.
McGarvey LP, Morice AH. McGarvey LP, et al. Respir Physiol Neurobiol. 2006 Jul 28;152(3):363-71. doi: 10.1016/j.resp.2005.11.011. Epub 2006 Jan 10. Respir Physiol Neurobiol. 2006. PMID: 16406741 Review.
74 results